Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria La Fe (34)

2025

  1. Autologous or Allogeneic Hematopoietic Stem Cell Transplantation as Front-Line Treatment for Adult Secondary Acute Myeloid Leukemia Patients: The PETHEMA Registry Experience

    Transplantation and Cellular Therapy, Vol. 31, Núm. 5, pp. 299.e1-299.e14

  2. Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Results of the PETHEMA PCR-LMA Study

    Cancers, Vol. 17, Núm. 5

  3. Hereditary transthyretin amyloidosis caused by the Val142Ile variant in Spain

    Revista Espanola de Cardiologia, Vol. 78, Núm. 9, pp. 768-777

  4. Left ventricular ejection fraction decline and cardiovascular events in suspected cardiomyopathy with excessive trabeculation: toward precision medicine

    Revista Espanola de Cardiologia, Vol. 78, Núm. 11, pp. 934-944

  5. Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery)

    Journal of the European Academy of Dermatology and Venereology, Vol. 39, Núm. 2, pp. 426-434

  6. Prognostic relevance of variant allele frequency for treatment outcomes in patients with acute myeloid leukemia: a study by the Spanish PETHEMA registry

    Haematologica

  7. Real-world patterns of immunoglobulin replacement therapy for infection prevention in common variable immunodeficiency: a multicenter nationwide study

    Frontiers in Immunology, Vol. 16

  8. Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study

    Journal of Hepatology, Vol. 83, Núm. 5, pp. 1069-1076

  9. Sex-specific response to cardiac resynchronization therapy: the BIO|WOMEN trial

    International Journal of Cardiology, Vol. 438

  10. The p.Asn271Ile Variant in the TNNT2 Gene Is Associated With Low-Risk Late-Onset Hypertrophic Cardiomyopathy

    JACC: Heart Failure, Vol. 13, Núm. 12

  11. Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study

    Cancer, Vol. 131, Núm. 1